Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cinacalcet for Persistent Secondary Hyperparathyroidism in Renal Transplant Recipients
NCT00415584Phase 2Terminated
- Sponsor
- Montefiore Medical Center
- Start
- Feb 2007
- Primary completion
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of cinacalcet in secondary hyperparathyroidism (SHPT), sponsored by Montefiore Medical Center. Primary endpoint: Normalization of Serum Calcium Levels at 6 months. Started Feb 2007; status: terminated.
02
Drugs
cinacalcet
03
Conditions
secondary hyperparathyroidism (SHPT)
Beyond the preview
Go deeper on NCT00415584.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00415584.